Switch to:
More From Other Websites
[$$] FDA Panel Recommends More Study on Testosterone Drugs Sep 17 2014
FDA panel backs limiting use of testosterone replacement drugs Sep 17 2014
Video: Gilead Stock Falls On These Drug Setbacks Sep 17 2014
AbbVie Sued by Pension Fund Over $54.5 Billion Shire Deal Sep 16 2014
Gilead Up As Analyst Lifts Sovaldi Q3 Estimate Sep 16 2014
Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote Sep 16 2014
EU mergers and takeovers (Sept 16) Sep 16 2014
Biogen/AbbVie Report Positive Data on MS Drug Zinbryta Sep 15 2014
EU to decide on $52 billion AbbVie, Shire deal by Oct. 16 Sep 15 2014
Shire eating disorder drug gets U.S. priority review Sep 15 2014
Hynes Keller & Hernandez, LLC Announces Investigation of World Acceptance Corp., PTC, Inc. and... Sep 15 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 12 2014
AbbVie's Humira Positive in Phase III Skin Disease Study Sep 12 2014
Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the... Sep 12 2014
AbbVie draws short-term calls Sep 12 2014
AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with... Sep 11 2014
Top U.S. Senate Democrats unveil earnings stripping plan Sep 10 2014
Top U.S. Senate Democrats unveil earnings stripping plan Sep 10 2014
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Sep 10 2014
[$$] Federal Trade Commission Sues AbbVie, Other Drug Companies Sep 09 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK